Principia Biopharma (PRNB) PT Raised to $66 at Stifel
Get Alerts PRNB Hot Sheet
Price: $100.05 --0%
Rating Summary:
4 Buy, 4 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 12 | Down: 23 | New: 22
Rating Summary:
4 Buy, 4 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 12 | Down: 23 | New: 22
Join SI Premium – FREE
Stifel analyst Derek C. Archila raised the price target on Principia Biopharma (NASDAQ: PRNB) to $66.00 (from $51.00) while maintaining a Buy rating.
You May Also Be Interested In
- Freedom Broker Upgrades PrimeEnergy Resource (PNRG) to Hold
- Samsonite International SA (1910:HK) (SMSEY) PT Lowered to HK$19.60 at Macquarie
- Candel Therapeutics Inc. (CADL) PT Raised to $15 at Freedom Broker
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share